Canaan Partners
http://www.canaan.com/homeCanaan Partners is a venture capital firm that invests in early stage technology and healthcare companies. Since its founding in 1987, Canaan has invested in more than 250 companies including DoubleClick and Match.com.
View Older Stories View More Recent Stories
-
Form 4 Canaan Partners X LLC For: Mar 20 Filed by: Protagonist Therapeutics, Inc
-
Form 4 Canaan Partners X LLC For: Mar 16 Filed by: Protagonist Therapeutics, Inc
-
Inaugural West Coast Drug Delivery Event Announced for May 2018
-
Form 4 Canaan Partners X LLC For: Mar 13 Filed by: Protagonist Therapeutics, Inc
-
MindTickle Appoints Sales Enablement Leader to Drive Excellence and Innovation
-
IDEAYA Biosciences Raises $94 Million Crossover Series B Financing
-
Arbe Robotics Wins Berlin’s Automotive Tech.AD Award
-
Snyk Secures $7M in Series A Round
-
BCD Travel Partners with Rocketrip to Change the Way Employees Think About Spending Money on Business Travel
-
Zugata Introduces Zugata Insights, AI-Powered Analytics to Measure, Monitor, and Improve Organizational Performance
-
Genesee & Wyoming (GWR) Reports Investment in Cargomatic
-
Genesee & Wyoming Announces Investment in Cargomatic
-
New York City Health Business Leaders (NYCHBL) Releases First-of-Its Kind Report That Evaluates State of Healthcare Venture Capital Investment in New York City
-
Rocketrip Saves Companies $208 Per Business Trip and More Than Doubles Enterprise Customer Base
-
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
-
Strong Growth in 2017 Among Health Systems and Payers Propels Glooko into 2018
-
Apartment List Secures $50 Million Series C Funding To Take Over U.S. Rental Market
-
Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director
-
UConn Technology Incubation Program Companies Raise $60M In 2017
-
Ladder Secures $30M In Series B Funding To Fuel Expansion
-
Genome Medical Launches Genetic Health Programs for Employer Groups
-
Genome Medical Expands Financing with Strategic Investments by GE Ventures, Kaiser Permanente Ventures and Illumina Ventures
-
JOOR Adds to Global Senior Leadership Team with Key Hires from Google, XO Group and Rakuten
-
Rocketrip Named One of the "Best Entrepreneurial Companies in America" by Entrepreneur Magazine's 2017 Entrepreneur360 List
-
Direct Travel Names Rocketrip as New Partner
-
Agile Stacks Completes Initial Funding Round Led by Canaan Partners
-
Agile Stacks Debuts Early Release of DevOps Automation Service that Enables Enterprises to Deploy Customized Cloud Container Stacks in Minutes
-
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
-
CircleUp And Nielsen Collaboration Fuels Growth Of Early-Stage Consumer Products
-
MindTickle Raises $27 Million in Series B Funding to Accelerate Product Innovation and Global Expansion
-
MindTickle Raises $27 Million in Series B Funding to Accelerate Product Innovation and Global Expansion
-
Rocketrip Names Dan Figenshu Chief Financial Officer
-
Adelman Travel Signs Agreement with Rocketrip
-
Leanplum Transforms Mobile Engagement for the Modern Marketer
-
Rocketrip Announces Duty of Care Integration
-
Rocketrip Wins 2017 Innovative Travel and Expense Technology of the Year Award from PayStream Advisors
-
Emissary Scales Intelligence Network With Entrance Into IT Market, Adding 3,000 Executive Advisors From Fortune 1000 Companies And Key Clients
-
Apartment List Acquires Talent Powerhouse, Maguire & Fish
-
HUM Nutrition Announces Series A Investment With Funding From CircleUp, Imaginary Ventures And Strand Equity
-
Leanplum Raises $47 Million to Build Next Generation Marketing Cloud
-
Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference
-
CircleUp Announces CircleUp Growth Partners, a New $125 Million Fund
-
A.I. Company Founded by Google’s Youngest Employee Partners with Former FBI Hostage Negotiator to Revolutionize Dealmaking
-
Clinical Data from Phase 1 PK/PD Study of Octreotide for Intranasal Delivery to be Presented at North American Neuroendocrine Tumor Society Symposium
-
Spyryx Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of SPX-101 for the Treatment of Cystic Fibrosis
-
Form 13F-HR Canaan Partners VII LLC For: Sep 30
-
Mynd Secures Additional 5 Million in Funding Led by Lightspeed Ventures
-
Zugata Partners With Skillshare and The Muse to Help Companies Deliver Personalized Professional Development
-
TechCrunch Disrupt San Francisco 2017 Announces Startup Battlefield Competitors
-
ExecThread Raises $6.5 Million to Accelerate Growth of its Crowdsourced Jobs Platform


